Drug Shortage Report for TEVA-LENOLTEC NO. 2

Last updated on 2017-09-05 History
Report ID 3118
Drug Identification Number 00653241
Brand name RATIO-LENOLTEC NO 2
Common or Proper name LENOLTEC
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE
Strength(s) 300MG 15MG 15MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-04-15
Actual start date
Estimated end date 2017-06-30
Actual end date 2017-07-30
Shortage status Resolved
Updated date 2017-09-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-09-05 French Compare
v6 2017-09-05 English Compare
v5 2017-05-08 French Compare
v4 2017-05-08 English Compare
v3 2017-04-16 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare

Showing 1 to 7 of 7